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    INTRODUCTION
          Lichen planus is a papulosquamous disease of the skin and mucous 
membranes. It is derived from two words, ‘leichen’ in Greek meaning tree moss 
and ‘planus’ in Latin meaning flat. Lichen planus is worldwide in distribution 
with a variable incidence. It is considered to be due to cell mediated immune 
response to an epidermal  antigen in genetically  predisposed persons.  Lichen 
planus has been found to be associated with certain infections and autoimmune 
diseases.
        In  its  classic  presentation,  the  disease  is  characterized  by  pruritic 
violaceous  papules  most commonly on the extremities of  middle aged adults. 
It may be accompanied by oral and genital mucosal involvement. Hair and nails 
may also be affected. Besides the typical lesions, there are many variants of the 
disease.
       The course of the disease is unpredictable. It  generally persists for a period 
of several months to years. Sometimes it may follow a chronic relapsing course. 
The duration varies  according to the extent  and site  of involvement and the 
morphology of the lesions.
m
      Though this condition is mostly self-limiting, sometimes the patient may 
have  considerable  discomfort  and  disability.  The  lesions  may  heal  with 
pigmentary changes and scarring. Malignant transformation may occur rarely.
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       Biopsy of fully developed lesions of lichen planus shows characteristic 
histological  changes.  Characteristic  staining  patterns  are  observed  in  the 
immunofluorescence study of the lesions.
       Treatment options are based on the extent and severity of the disease. 
Symptomatic treatment is usually sufficient. In severe cutaneous and mucosal 
lichen planus, various other treatment approaches are useful.  Glucocorticoids 
(topical,  intralesional,  systemic),  cyclosporine,  antimalarials,  dapsone, 
thalidomide,  azathioprine,  phototherapy,  doxycycline,  interferons  have  been 
found to be effective.
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REVIEW OF LITERATURE
   
 HISTORICAL ASPECTS:
-Hebra first described the disease as leichen ruber.
-In 1869, Erasmus Wilson named the condition leichen planus.
-Kaposi described lichen ruber pemphigoides in 1892.
-In 1895, Louis Federic Wickham described whitish streaks on the surface of 
the papules.
-Histologic findings were elaborated by Darier in 1909.
 -Scalp and follicular involvement reported initially by Graham Little in 1919.
-In  1935,Gougerot described the entity, invisible pigmented lichen planus.
-In 1956,Shima described lichen planus pigmentosus.
-In 1982, Pelisse et al described vulvovaginal gingival lichen planus.
-In 1993, Cribier et al described peno gingival lichen planus.
-In 1983,Olsen et  al  demonstrated lichen planus specific  antigen by indirect 
immunofluorescence technique using autologous lesional skin1. 
EPIDEMIOLOGICAL ASPECTS OF LICHEN PLANUS
INCIDENCE:
  The  exact  incidence  and  prevalence  of  LP  are  unknown,  but  the  overall 
prevalence is believed to be less than 1% of the general population2.Estimates 
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between 0.14 to 0.80%  have been reported worldwide. An incidence of 0.38% 
has been reported from India 3.
AGE:
LP most commonly affects middle aged adults though any age can be affected. 
Childhood LP is rare4.About 2/3rd   cases occur between 30-60 years of age4.It is 
less common in very young and elderly.
SEX:
LP affects both sexes. A slight female preponderance has been reported2.Males 
have an earlier age of onset (4th decade) than females(5th decade).
RACE:
No racial predilection has been noted5.
SEASONAL FACTORS:
 No seasonal variation has been reported by some authors. One study reported a 
high incidence in December and January6.
FAMILIAL FORM:
A familial  form of the disease exists but is rare7.Monozygotic twins may be 
affected. Association with HLA haplotypes HLA-B7,-Aw19,-B18,-Cw8  noted 
in familial forms.
ETIOPATHOGENESIS OF LP:
10
Exact  cause  of  LP  is  not  known.  Immunological  reaction  plays  role  in  the 
pathogenesis of LP. There is evidence of genetic and environmental influences.
HLA-B7,-Aw19,-B18,-Cw8  are  associated  with  familial  LP10.In  nonfamilial 
cases, HLA-A3,-A5,-B8,-Bw35 are more common8. HLA-B8 is more common 
in patients with oral LP9.
Infectious agents,drugs,stress,allogenic cells are known to be involved in the 
pathogenesis of LP and lichenoid reactions.Hepatitis C virus infection has been 
associated with LP10.
Drugs  like  antimalarials,  gold,  frusemide,  thiazides,  penicillamine  and 
spironolactone are known to cause LP like lesions11.Dental amalgam materials 
are known to cause oral lichenoid reactions12.
Studies have shown that LP represents a cell-mediated immune response to an 
induced antigenic change in the epidermal cells  in a genetically predisposed 
individual13.  CD8+ infiltrates  in  the  lesional  skin  recognize  a  MHC Class  I 
antigen called lichen planus specific antigen (LPSA), the exact nature of  which 
is unknown. This may be an auto-reactive peptide or exogenous antigen such as 
altered protein, drug, contact allergen and viral or other infectious agent14.
The  pathogenic  role  of  HCV  in  the  development  of  LP  is  still 
unclear.Nevertheless,  demonstration of  HCV RNA in  epithelial  cells  of  oral 
mucosa and skin lesions  of patients with LP would lead to the theory that direct 
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action of the virus is involved. HCV could be a potential antigen presented by 
Langerhans  cells,  followed  by  activation  and  migration  of  lymphocytes 
resulting in damage to basal cells via cytokines of cytotoxic T cells.The virus 
may alter epithelial antigenicity at sites of mucocutaneous replication leading 
either to direct activation of cytotoxic T cells  or to production of antibodies 
against epithelial antigens15.
Activation  of  cell  mediated  immune  response  destined  towards  keratinocyte 
apoptosis is the prime event  in the pathogenesis of LP.The process involves 
three sequential stages:
             1.LPSA recognition
             2.cytotoxic lymphocyte activation
             3.keratinocyte apoptosis
Antigen recognition is followed by CD8+ T cell activation.There is release of 
IL-2,IL-4,IFNγ,TNFα.IFNγ  enhances  expression  of  adhesion  molecules 
ICAM-1,VCAM-1 by basal cells,langerhans cells & other dendritic cells.There 
is increased concentration of collagen IV, collagen VII, laminin 5 which act as 
ligands for β1 integrin on the surface of lymphocytes.The interaction between 
lymphocytes & basement membrane targets metalloproteinases and the process 
leads to  basement membrane disruption16.
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Mechanism of keratinocyte apoptosis:
-T cell secreted TNFα binds to TNFα R1 receptor on keratinocyte surface.
-T cell surface CD95 L (Fas ligand) binds to CD95 (Fas) on the keratinocytes.
-T  cell  secreted  Granzyme  B  enters  the  keratinocyte  via  perforin  induced 
membrane pores.
All these mechanisms activate caspase resulting in keratinocyte apoptosis17.
CLINICAL FEATURES:
The classical  lesions  of  cutaneous  LP are  violaceous,  flat  topped polygonal 
papules  associated  with  intense  itching.  The  sites  of  predilection  are  flexor 
surface of wrists, trunk& thighs18. Oral cavity, genitals, nails and scalp may also 
be involved19.Oral involvement may be the only manifestation20.Involvement of 
face, palms, soles may also be present21.
Lesions  appear  along scratch  marks  or  trauma.  This  is  known as  koebner’s 
(isomorphic) phenomenon. Fine, white reticulate pattern on the surface of the 
papules known as wickham’s striae is seen which is better visualized with a 
hand  lens  after  applying  oil.  The  lesions  generally  heal  with 
hyperpigmentation.
Classification of  lichen planus 28:
Based on lesional morphology:
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Hypertrophic LP
Atrophic LP
Guttate ( eruptive) LP
Annular LP
Follicular LP
Linear LP
Vesiculobullous LP
Ulcerative LP
LP pigmentosus
Based on site of involvement:
Mucosal LP
Palmoplantar LP
Nail LP
Inverse LP
Special forms:
Drug induced LP
Actinic LP
LP pemphigoides
Lichen planus- lupus erythematosus overlap
HYPERTROPHIC LP:
14
Verrucous  plaques  occur,commonly  over  shins,  ankles22.There  is  central 
depigmentation with surrounding hyperpigmented rim.The lesions are intensely 
pruritic  and  heal  with  scarring.They  may  persist  for  years.Squamous  cell 
carcinoma may arise from long standing lesions23.
ATROPHIC LP:
It is a rare form with well defined papuloplaque lesions with central atrophy. 
Usually typical papules are present at the margins24.
ANNULAR LP:
This  type  is  commonly  seen  on  glans  and  shaft  of  penis.  Central  atrophy 
surrounded by a thin rim of active erythema is characteristic25.The lesions tend 
to have a chronic course.
LINEAR LP:
This form represents only 0.25% of the different clinical patterns. It is more 
common in childhood.  Sometimes,  it  may follow dermatomes (segmental  or 
zosteriform)  or lines of Blaschko26.
GUTTATE OR ERUPTIVE  LP:
Multiple, small erythematous lesions, pinhead to 1 cm size occur as recurrent 
crops  in a widespread, generalized distribution27 .
FOLLICULAR LP:
It is also called as Lichen planopilaris. It presents as violaceous or pigmented 
follicular hyperkeratotic papules on trunk, medial aspect of extremities, scalp. 
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Cicatricial  alopecia  is  a  sequelae.  In   Graham  Little  Piccardi  Lassueur 
syndrome, there is follicular LP of scalp or body, multifocal cicatricial alopecia 
of scalp and non cicatricial alopecia of axilla and pubic areas29.
ULCERATIVE LP:
This presents as chronic, disabling,painful ulceration of the soles. It may cause 
permanent loss of toe nails. This type is important because it may be a site for 
malignant transformation30.
LICHEN PLANUS PIGMENTOSUS:
This form is mainly seen in darker races. It is characterized by slate gray to dark 
brown  macules  over  sunexposed  areas,  trunk  and  flexures.  The  lesions  are 
asymptomatic and may be patchy, reticular, follicular or diffuse. Some believe it 
to be similar  to ashy dermatosis31.
INVERSE LP:
 Flexural  sites  like  axillae,  groin,  inframammary  region  are  predominantly 
affected.
ACTINIC LP:
It  is  also  called  as  LP  subtropicus  &  is  seen  in  young  adults  in  tropical 
countries.Sunlight  is  considered  as  predisposing  factor32.Well  defined 
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violaceous patches surrounded by a hypopigmented rim is seen mainly over the 
face,neck and dorsum of hands.
BULLOUS LP:
Vesiculobullous lesions may develop over the LP lesions during acute flare. 
Familial bullous LP is a rare autosomal dominant condition with bullous lesions 
on extremities.It has an earlier onset and widespread distribution33.
LP PEMPHIGOIDES:
It is a rare variant with features of lichen planus and bullous pemphigoid. Tense 
bullae  occur  on  extremities  from  both  involved  and  uninvolved  skin. 
Degeneration of basal cells leads to exposure of basement membrane antigens 
which stimulate the production of circulating antibodies to BP 180 KDa & BP 
200 KDa antigens34.
ORAL LP:
Upto 65% of patients with cutaneous LP have oral involvement. Isolated oral 
involvement  can  occur  in  about  15-35%35.Sites  of  involvement  are  buccal 
mucosa, gingiva, tongue, palate &lips. The subtypes are reticulate, erosive or 
ulcerative,  bullous,  atrophic  &  plaque  types.  Reticulate  pattern  is  the  most 
common with irregular  atrophic plaques with white streaks in a lacy pattern 
over  the  buccal  mucosa.Oral  LP  may  be  asymptomatic  or  cause  pain  and 
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burning sensation.Oral  LP especially the erosive type is prone for malignant 
transformation36.
.
GENITAL LP:
This may occur alone or with oral or with generalized involvement. In females, 
painful vulval erosions with lacy reticulate borders occur. Scarring may occur. 
A  variant  of  mucosal  LP  termed  as  vulvovaginal  gingival  syndrome  is 
characterized  by  erosions  and  desquamation  of  vulva,vagina  & gingiva37.  A 
male equivalent of this syndrome has been described as penogingival syndrome. 
In males,  annular  LP is more common. Lesions are seen over glans,shaft  of 
penis,prepuce and scrotum38.
NAIL LP:
Isolated nail LP is rare and it may cause twenty nail dystrophy39.Nail is involved 
in  10-15%  cases.  The  most  common  findings  are  nail  plate  thinning, 
longitudinal  ridging  ,onychoschizia,  onychorrhexis  and  sometimes 
anonychia40.Pterygium is a classical finding.
PALMO PLANTAR LP:
It presents as yellowish hyperkeratotic plaques commonly over lateral margins 
of fingers and instep of sole41.
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 LUPUS  ERYTHEMATOSUS/LICHEN  PLANUS  OVERLAP 
SYNDROME:
This shows clinical, histological and immunopathological characteristics of both 
disorders. It may occur as bluish red atrophic plaques or verrucous papules and 
nodules over photodistributed  areas  or  acral  portion of extremities42.
                            COMPLICATIONS
-Generalised LP lesions may give rise to erythroderma43.
-Lichen planopilaris may lead to scarring alopecia44.
-Nail LP may result in anonychia or dystrophy45.
-post inflammatory pigmentary changes.
 -Risk of malignant transformation in certain variants like oral LP, hypertrophic 
LP,ulcerative LP46,47.
                                ASSOCIATED CONDITIONS
In the past few years, lichen planus has been linked to HCV infection , with 
studies  demonstrating  a  higher  prevalence  of  anti-HCV  antibody  titers  in 
patients with cutaneous and oral lichen planus, compared with control subjects. 
The  reported  rates  of  association  have  differed  widely,  probably  because  of 
varying study design, oral versus cutaneous lichen planus and geography48-
52.Clinical  variants  associated  mostly  are  oral  LP,rarely  eruptive  and  linear 
LP51,53,54. 
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Cutaneous lesions which have been reported in association with LP are alopecia 
areata62-64,vitiligo62, morphea65,67, lichen sclerosus67, dermatomyositis68,systemic 
lupus erythematosus66, pemphigus vulgaris 69and paraneoplatic pemphigus70.
 LP has been reported in association with diabetes  mellitus  particularly  oral 
LP55.The association of oral LP with diabetes & arterial hypertension is known 
as Grinspan syndrome.
 The  systemic  disorders  associated  with  lichen  planus  are  ulcerative 
colitis56,thymoma57,  myasthenia  gravis58,primary  biliary  cirrhosis59,  primary 
sclerosing  cholangitis60 and  acquired  hypogammaglobulinemia61.
DIAGNOSIS:
The diagnosis of lichen planus is clinical.  In case of doubt,  a biopsy should 
establish the diagnosis.
Histopathology of a classical lesion shows the following :
Compact orthokeratosis
Wedge shaped hypergranulosis  (clinically wickham’s  striae)
Vacuolar alteration of basal layer71
Band- like lymphocytic infiltrate in close approximation to the epidermis
B
This  constellation  of  findings  is  sufficiently  diagnostic  that  a  histologic 
diagnosis can be made in more than 90%72.
Civatte bodies:
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They are necrotic keratinocytes present in most cases in lower epidermis and 
especially in papillary dermis. They are also known as colloid, hyaline or cytoid 
bodies. They are 20 μ in diameter, homogeneous, eosinophilic PAS positive and 
diastase resistant73.
Max Joseph space:
Occasionally,  small  areas  of  artifactual  separation  between  epidermis  and 
dermis are seen74.
The rete ridges show irregular lengthening and some are pointed at their lower 
end, giving a saw toothed appearance75.
The infiltrate in upper dermis is band like and sharply demarcated at its lower 
border  and  is  composed  almost  entirely  of  lymphocytes  intermingled  with 
macrophages76. A few eosinophils and plasma cells may be seen. Melanophages 
are  seen  in  upper  dermis  due  to  damage  of  the  basal  layer  and  pigment 
incontinence77.
Hypertrophic LP:
Considerable   acanthosis,  papillomatosis,  hyperkeratosis  and hypergranulosis 
are seen. The interface changes are discrete and often limited to the base of the 
rete ridges78.
Atrophic LP:
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There is thinning of the epidermis upto the granular layer and effacement of 
rete ridges79.
Ulcerative LP:
Epidermal ulceration is present with typical changes of  LP at the margin of the 
ulcer80.
Follicular LP:
Orthokeratosis,  follicular  plugging and wedge shaped hypergranulosis  of  the 
infundibulum, vacuolar changes of basal layer of outer root sheath and necrotic 
keratinocytes are seen with focally dense band-like perifollicular lymphocytic 
infiltrate at the level of infundibulum and isthmus . Interfollicular epidermis is 
often spared. In later stages, perifollicular fibrosis& epidermal atrophy give rise 
to  hour glass configuration81.
Bullous LP:
Typical features of LP with subepidermal bulla and heavy dermal infiltrate with 
numerous colloid bodies are seen82.
LP pemphigoides:
Biopsy of uninvolved skin shows subepidermal bulla with an infiltrate that is 
not band-like and which contains plenty of eosinophils83.
Actinic LP:
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There  is  thinning  of  epidermis  towards  the  centre  of  the  lesion  with  more 
evident pigmentary incontinence in upper dermis84.
LP pigmentosus:
Typical features of LP seen with pronounced pigment incontinence extending to 
reticular dermis and less prominent inflammatory infiltrate85.
LE/LP overlap:
A lichenoid reaction typical for LP and histological features of LE are usually 
present in the same biopsy86.
Drug induced LP:
Parakeratosis,  numerous  eosinophils  and  perivascular  inflammation  are  seen 
which are absent in classical LP. 
Mucosal LP:
Epithelium is  often atrophic.  There is  parakeratosis  and absence of  granular 
layer. There are fewer colloid bodies87.
Nail LP:
Usual changes of LP are present.The granular layer which is normally absent, is 
present.Colloid bodies are rare88.
DIRECT IMMUNOFLUORESCENCE IN LICHEN PLANUS:
Procedure:
A 4 mm punch biopsy is taken from lesional skin.
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If there is delay of more than 24 hours before processing, the specimen is kept 
in Michel’s medium which contains 5% ammonium sulfate, magnesium sulfate, 
N -ethyl maleimide in citrate buffer (pH 7.25).
While processing,  the specimen is washed several times in phosphate buffer 
saline and 5 micron thick sections are made. The sections are stained with IgG, 
IgA, IgM, fibrinogen and C3 antibodies labelled with fluorescein isothiocyanate 
and then visualized in fluorescent microscope89.
DIF Pattern:
In  LP,  shaggy  deposits  of  fibrinogen  at  the  dermo  epidermal  junction  is 
characteristic90.
Necrotic keratinocytes are demonstrable in 87% of cases. They stain mainly for 
IgM but also for IgG,IgA,C3 and fibrin91.
In lichen planopilaris, deposition of IgM, IgA, IgG, C3 occurs at the level of 
infundibulum and isthmus. There is often deposition of fibrinogen in a shaggy 
pattern surrounding the affected follicles92.
In LP pemphigoides, DIF of perilesional skin shows IgG & C3 in linear pattern 
along BMZ93.
In  LE/LP  overlap,  the  most  common  finding  is  presence  of  cytoid  bodies 
staining  with  IgG,IgM&C3  intraepidermally  or  at  BMZ.  Linear  to  granular 
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deposition  of  IgM&C3  are  observed  occasionally.  Shaggy  deposition  of 
fibrinogen at the BMZ is sometimes found94.
 INDIRECT IMMUNOFLUORESCENCE IN LICHEN PLANUS:
IIF  is  of  particular  help  to  differentiate  atypical  cases  of  LP  from  other 
dermatoses.
Lichen planus specific antigen  (LPSA) can be demonstrated using the patient’s 
serum &  autologous  lesional  skin.
PROCEDURE:
A  4 mm punch biopsy is taken from lesional skin, snap frozen and sections are 
taken using cryostat.
5 ml of patient’s blood is collected and serum is separated.
Serum (1:10 and 1:80 dilution) is incubated with lesional skin sections for one 
hour & washed in PBS.
It is then incubated with various fluorescein isothiocyanate conjugates for one 
hour & washed again in PBS .It is mounted in buffered glycerol and examined 
under fluorescent microscope95.
IIF Pattern:
LPSA is specific  for lichen planus and is found in 80% of patients. IIF using 
autologous lesional  skin shows characteristic  fluorescent  IgG deposits in the 
upper epidermis at the level of stratum granulosum and stratum spinosum96.
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                                 AIM OF THE STUDY 
1.To find out the clinical profile of lichen planus seen among patients attending 
the skin OPD.
2.To find out the dermatological and systemic associations and complications if 
any.
3.To correlate the clinical and histopathological features of various types of LP.
4.To know the immunofluorescence patterns of LP.
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       Materials and Methods
           The material for this study was from the patients attending the skin OPD, 
Government  Rajaji  Hospital,  Madurai  Medical  College,  Madurai  during  the 
period from July 2008 to July 2009.
Inclusion criteria:
Patients diagnosed clinically as lichen planus  during the study period.
Exclusion criteria:
Patients  who  did  not  give  consent  for  biopsy  were  not  subjected  to  biopsy 
procedure but were included in  the  study of  the clinical profile.
             A total of  90 patients were clinically diagnosed as lichen planus during 
this period and were taken for the study. A detailed clinical history including 
duration, site of onset, symptoms, drug  history, family history were elicited. A 
complete  general  examination,  systemic  examination  and  dermatological 
examination were made. Digital photographs were taken.
          The morphology and distribution of skin lesions, presence of any other 
associated diseases were noted. Concomitant affection of mucosa, hair, nails, 
palms, soles, genital involvement was meticulously recorded.
        Laboratory investigations  like urine examination,  blood sugar,  urea, 
creatinine, liver function tests, anti HCV antibody, blood VDRL and complete 
hemogram were done.
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         Skin biopsy was done in 50 patients who gave informed consent. After 
thorough cleaning of  the part  to be biopsied with spirit,  2% lignocaine was 
infiltrated into the area and a bit of the lesional skin was removed by punch 
biopsy.  The  specimen  were  preserved  in  10%  formalin  and  submitted  for 
histopathological examination to the department of Pathology, Madurai Medical 
College.
    Out of the 50 patients in whom histopathological examination was done, 
direct   immunofluorescence study could be done in  only 20 patients  due to 
financial constraints. The lesional skin was biopsied and specimen preserved in 
Michel’s  medium  and  sent  to  the  department  of  Skin  and  STD,  Kasturba 
hospital, Manipal.
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OBSERVATIONS AND RESULTS
                     
         In this study, 90 cases of lichen planus were studied from the outpatient 
department  of  dermatology,  Government  Rajaji  hospital,  Madurai  medical 
college, from July 2008 to July 2009.The following observations were made. 
Apart from the classical presentation which was seen in most patients, the other 
types of LP encountered were hypertrophic, eruptive, linear, annular, follicular, 
actinic, LP pigmentosus,  LE/LP overlap and isolated oral LP.
Table 1:  Clinical types of LP
Clinical type of LP No of pts Percentage(%)
Classical
Hypertrophic
Eruptive
LP pigmentosus
Linear 
 Isolated oral 
Annular 
Follicular
LE/LP overlap
Actinic 
60
10
4
3
 5
2
2
2
1
1 
 
 66.66
 11.11
 4.44
 3.33
 5.55
 2.22
 2.22
 2.22
 1.11
 1.11
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   Classical  lichen  planus  was  the  commonest  type  (67%),  followed   by 
hypertrophic  type  (11%),  linear  variant  (5.5%),  eruptive  type  (4%),  lichen 
planus  pigmentosus(3%).  Isolated  oral  LP  was  seen  in  2%.  Annular  LP, 
follicular LP,  LE/LP overlap  and actinic LP  were the other types seen.
AGE DISTRIBUTION
Table 2. The age of onset:
Age of 
onset Class Er
LP 
Pigm Oral Ann HT Linear Actinic Foll LE/LP
0-10  3 1 - - - - 2 -   -
-
11-20 3 2 1 - - - 1 1   -
-
21-30 12 - - - 1 2 1 -   -
-
31-40 15 1 2 1 1 3 - -   1
-
41-50 18 - - 1 - 3 - -   -
-
51-60 6 - - - - 2 1 -   -
1
61-70 3 - - - - - - -   1
-
30
Total 60 4 3 2 2 10 5 1   2
-
Class = classical                                HT = hypertrophic 
Er = eruptive                                     Foll = follicular
LP Pigm = LP pigmentosus
Ann = annular 
                 
Age group Number Percentage 
0-10 yrs
11-20 yrs
21-30 yrs
31-40 yrs
41-50 yrs
51-60 yrs
61-70 yrs
6
8
16
24
22
10
4
6.67
8.88
17.77
26.66
24.44
11.11
4.44
The majority of patients were in the age group of  31-50 years .The number of 
patients in each age group were as follows:
Table 3:
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Sex distribution:
44 patients were males and 46 were females. 
Table 4: sex distribution\
Types Of LP Male Female
Classical LP            27           33
Eruptive LP             3             1
LP Pigmentosus             1             2
Oral LP             -             2
Annular LP             2             -
Hypertrophic             7             3
Linear LP             3             2
Actinic LP `           -             1
Follicular LP             1             1
LE/LP Overlap             -             1
Initial site of  onset was limbs in  63%, trunk in 21%,face in 8%,genitals in 2% 
and oral mucosa in 6%. Papules were present in 79%  and plaques were present 
in 14% of the cases. Koebner’s phenomenon was seen in 33% of the patients. 
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Table 5: childhood LP:
S.no Age Sex Clinical type Mucosal 
Inv.
Palm/sole
Inv.
Nail 
Inv.
1.
2.
3.
4.
5.
6.
7.
8.
10 yrs
11 yrs
5 yrs
6 yrs
12 yrs
4 yrs
8 yrs
8 yrs
F
M
M
F
M
M
M
F
Classical
Linear 
Classical 
Classical
Eruptive 
Eruptive 
Linear 
Linear 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
P
-
-
-
-
-
Symptoms :
The  presenting  symptoms of  the patients were itching in 73% and 7% had 
pain in the lesions involving oral mucosa and 20% were asymptomatic.
Mucosal involvement : 
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Oral  mucosal involvement  was seen in 19 patients and genital mucosal 
involvement was noted in 2 patients .
                            Table 6: Mucosal involvement :
Clinical type Oral mucosa Genital mucosa
Classical LP 13 -
Eruptive LP                        - -
LP Pigmentosus                        - -
Isolated oral LP                       2 -
Annular LP                        - 2
Hypertrophic LP                       3 -
Linear LP
                       -
-
Actinic LP `                      - -
Follicular LP                        - -
LE/LP Overlap                        1 -
Oral mucosal involvement :
Patterns of oral mucosal involvement seen were reticular, erosive and plaque 
types.
Cheek mucosa and lips were the common sites affected.
    Table 7: Patterns of oral mucosal involvement
Pattern Reticular Erosive Plaque 
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No of pts.
     
  11
     
   3
     
  5
Genital involvement :
Genital involvement was seen as annular lesions over glans penis in 2 patients
 and papules over shaft of penis and scrotum in 7 patients. Genital involvement 
was not present in the female patients. 
Table 8: Genital involvement:
Types Of LP No. Of Patients With genital Involvement
Classical LP
                                
              
                 6
Eruptive LP
                                 
            
                1
35
Annular LP
                                
                2
 
Nail involvement:
Nail involvement was seen in 16 cases. Longitudinal ridging, pterygium, 
thinning  of nail plate, onychomadesis,trachyonychia were commonly seen.
Nail Involvement was present in 14 cases of classical LP and 2 cases of 
hypertrophic LP.
Table 9:Nail involvement:
Findings No of pts.
36
Longitudinal ridging
Pterygium unguis
Nail plate thinning
Trachyonychia
Onychomadesis
Longitudinal melanonychia
onychoschizia
Punctuate leuconychia
4
3
2
2
2
1
1
1
Palmoplantar LP:         
Palmoplantar involvement was seen in 18cases. It was seen in 14 cases of 
classical type, 3 cases of hypertrophic type and 1 case of eruptive LP.
Involvement of  palms and soles was characterized by hyperkeratotic  scaly 
plaques.
Table 10: Palmoplantar LP
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Types Of LP No. of pts with Palmo-plantar Involvement
Classical LP         14
Eruptive LP           1
LP Pigmentosus           -
Oral LP           -
Annular LP           -
Hypertrophic LP           3
Linear LP           -
Actinic LP           -
Follicular LP           -
LE/LP Overlap           -
 
Associated diseases:
The diseases which were found to be associated were diabetes mellitus, 
hypertension , vitiligo,  albinism , alopecia areata  and hypothyroidism.
Table 11: associated diseases:
38
Type of LP DM HT Vo AA Albinism hypothyroid
Classical LP 3 1 - 1 1 2
Hypertrophic 2 1 - - - -
 
Oral LP 1 - - - - -
 
Actinic LP - - 1 - - -
The direct immunofluorescence findings were as follows:
Table 12:DIF findings:
Findings Classical LP
Hypertrophic 
LP LE/LP
LP 
Pigmentosus
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Coll
oid 
Bod
ies
IgG
C3
IgM
IgA
Fibrin
2
3
6
4
3
1
2
3
2
2
-
-
1
-
-
-
2
2
1
1
BM
Z 
Dep
osit
s
Ragged
Fibrin
 IgG
 C3
13
3
3
4
-
-
1
1
1
2
-
-
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4Biopsy Findings
Classical LP
HT LP
Oral LP
LP Pigmentosus
Linear LP
Follicular LP
Actinic LP
LE/LP
Eruptive LP
Orthohyperkeratosis
26
9
-
-
2
2
-
1
2
Parakeratosis
2
-
2
-
-
-
-
-
-
Focal Hypergranulosis
26
9
-
1
2
-
-
1
2
Acanthosis
25
9
-
1
2
-
-
-
2
Epidermal thinning
-
-
-
-
-
-
1
-
-
Sawtooth rete
24
9
1
1
2
-
-
-
2
Follicular plugging
-
-
-
-
-
2
-
1
-
Basal layer degeneration
28
9
2
3
2
2
1
1
2
Pigment incontinence
27
9
2
3
2
2
1
1
2
Colloid bodies
10
4
-
3
-
-
1
1
-
  Infiltrate 
Band like lym.at BMZ 
28
-
2
3
2
2
1
-
2
2
   
Lym. mainly at base of rete
-
9
-
-
-
-
-
-
-
perifollicular lym.      
2
-
-
-
-
2
-
1
-
Eosinophil infiltrate            
2
-
-
-
-
-
-
-
-
patchy lym.& perivascular inf.
-
-
-
-
-
-
-
1
-
Features of squamous cell  carcinoma
-
1
-
-
-
-
-
-
-
 DISCUSSION
Incidence:
In our study, the incidence of lichen planus was 0.16 percent among 57,684 new 
patients attending the Skin OPD during the period from July 2007-July 2008.
Age distribution:
The age of the patients ranged from 4 to 68 years. The majority of patients (46 
patients or  51%) fall  in the age group from 31-50 years which is similar to 
studies done by Singh et el and Bhattacharya et al97,98.Various studies show that 
childhood involvement is uncommon100-102.In our study, childhood LP was noted 
in 9%(8 patients).
Sex distribution:
Predominance of males was reported in few studies97 while the reverse has also 
been reported99. Equal ratio has also been reported98. In our study, almost equal 
involvement  was  noted.  44  patients  were  males  and  46  were  females.  In 
childhood LP, 5 were males and 3 were females with a male: female ratio of 
1.6:1.
Clinical features:
                   Limbs are the most prevalent site of onset of LP as stated by Altman 
and Perry who reported a frequency of 89 percent103. This was the case in our 
study, with  initial limb affection of  57 patients ( 63%).The initial site of onset 
was trunk in 19 cases(21%),face in 7 cases(8%),genitals in 2% and oral mucosa 
in 5 cases(6%). Papules were present in 79%  and plaques were present in 14% 
of the cases.
            Prior history of drug intake was present in 12 patients. Itching was the 
main complaint in 73% percent of our patients, which was severe in patients 
with hypertrophic lesions. Itching was relieved by rubbing in 60 percent and by 
scratching in 13 percent of patients. Scratching was sometimes evidenced by 
excoriations and scratch marks. Koebner’s phenomenon was seen in 33% of the 
patients.
              Classical lichen planus was the commonest type (67%) which is in 
concordance  with  the  literature97-100,104.Classical  type  was  followed  by 
hypertrophic  type  (11%),  linear  variant  (5.5%),  eruptive  type  (4%),  lichen 
planus pigmentosus (3%).Isolated oral LP accounted for 2%. Annular LP was 
present in 2% and follicular LP was present in 2%.1 case had features of LE/LP 
overlap and actinic LP was seen in one case. Classical, linear and eruptive types 
were seen in children.
             Studies reveal predominance of the classic type among LP patients 
followed by the hypertrophic and the actinic varieties  97,98,105  .Our study shows 
predominance  of  classic  LP  followed  by  hypertrophic  LP.  However,  linear 
variant which is reported to be relatively rare was the next common in our 
study. As a result of cutaneous mosaicism, individuals may have distinct cell 
populations within their skin that are more likely to develop a skin condition . 
Linear LP is an example of this phenomenon and accounts for less than 0.2 
percent of all patients with LP106.
          In one patient, zosteriform pattern on the trunk  coexisting with linear 
pattern on the limb was seen. The patient had no past history of herpes zoster at 
the  site  of  the  lesion.  Zosteriform configuration  is  reported  to  be  rare107-112. 
Altman and Perry  reported only 1 case out of 307 cases of LP.
Oral lesions:             
             Oral LP associated with cutaneous lesions was detected in 17 patients 
and 2 patients had isolated oral LP . Plaque type, erosive and reticular patterns 
were seen in 5,3,11 patients respectively. Cheek mucosa, lips, tongue, gingiva 
were affected. From the different types of oral lesions, the reticular type was the 
most prevalent and the buccal mucosa was the most common site affected, an 
observation supported by the literature 119.
          Genital lesions were observed in 9 male patients (10%).Genital LP 
appeared as annular plaques on glans penis in 2 patients  and small papular 
lesions on shaft of penis, scrotum in 7 cases. Genital lesion was not present in 
any of the females.
a
         Nail changes were seen in 16 patients(18%). Pterygium was detected only 
in 3 of the patients. Apart from pterygium formation, the changes which were 
noted were longitudinal  ridging of the nails , onychomadesis ,trachyonychia, 
nail  plate  thinning,  longitudinal  melanonychia,  onychoschizia  &  punctuate 
leuconychia.
         Palmoplantar LP with accompanying skin involvement accounted for 
20% of  our  cases.  It  was  characterized by the presence  of  very pruriginous 
hyperkeratotic  scaly plaques as reported in the literature .
Mucosal and palmoplantar involvement were not seen in the childhood cases. 
Only  one  case  had  nail  involvement.  This  observation  is  similar  to  other 
studies120.
 HCV association:   
     Various studies conducted in different parts of the world have either proved 
or disproved a causative role for HCV in LP121-125. It has been suggested that 
routine liver function tests and further screening on the basis of abnormal values 
will  be  a  fair  enough  protocol  to  follow,  especially  in  areas  where  the 
prevalence of HCV infection is low 126.In our study ,abnormal LFT was seen in 
5  patients.  They were  tested for  anti  HCV antibody and were found to  be 
negative.
n
 Other associations:
Diabetes mellitus was present in 6 patients(6.6%).Hypertension was present in 2 
cases(2.2%).2 patients had hypothyroidism. Vitiligo was present in a case of 
actinic LP. Alopecia areata was seen in one patient. Lichen planus was seen in 
an albino child as scaly nonpigmented itchy papules. Squamous cell carcinoma 
complicating a case of hypertrophic LP was seen.
Diabetes,  hypertension  ,  hypothyroidism are  reported  to  be  associated  with 
lichen planus127,128.
Ahmed et al reported a case of co-existence of vitiligo and actinic lichen planus 
with  possibility  of  common  aetiological  background129.  Co-existence  of  two 
disorders  may  be  due  to  a  prominent  immunological  component  in  their 
pathogenesis.  In  vitiligo  autoimmune  hypothesis  is  suggested  by  its  clinical 
association with number of disorders. In lichen planus, probably autoimmunity 
plays a role as suggested by Shuttleworth et al130.
 
 
Histopathology :
                The classical histopathological changes were seen in all the cases of 
lichen planus. 
                  Epidermal changes were characterized by orthohyperkeratosis 
(84%), focal hypergranulosis (80%), and acanthosis (78%) with toothing of rete 
ridges  (78%)  and  basal  cell  liquefaction  (100%).  Epidermal  thinning  was 
observed in the case of lichen planus actinicus.  Hypertrophic  LP had more 
marked hyperkeratosis and acanthosis and  follicular plugging was present in 
lichen planopilaris. 
                  Dermal changes were char
acterized by a band-like inflammatory infiltrate pre
dominantly  of  lymphocytes  with  a  few  macrophages  hugging  the  dermo-
epidermal junction in most  of the cases.  In lichen planopilaris,  perifollicular 
involvement was present. A prominent perivascular infiltrate was observed in 
the case of LE/LP overlap.
                Two cases of classical LP showed parakeratosis and prominent 
eosinophilic infiltrate in addition to the lymphocytic infiltrate. Both of them had 
history of drug intake, one patient was on captopril and the other patient was on 
chlorpromazine. A diagnosis of drug induced lichen planus was made based on 
the drug history and histological findings.
t
            Both linear LP and eruptive  LP showed features similar to classical type 
histologically.
            Pigment incontinence in the form of melanophages was seen in the 
superficial dermis in all cases except one in the case of lichen planus in a child 
with albinism. Civatte bodies were seen in only 36% of cases. They were seen 
as round, eosinophilic  bodies in the lower epidermis  and papillary dermis. 
Colloid bodies were observed in large numbers in the case of actinic LP & LP 
pigmentosus. Features of squamous cell carcinoma was seen in the biopsy of 
warty  growth in a case of hypertrophic LP.
Direct immunofluorescence:
A  ragged  fibrin  band  at  the  basement  membrane  zone  was  the  most 
characteristic  finding  ,  being  seen  in  all  the  20  patients.  Colloid  bodies 
demonstrating lgM, C3, lgG, or lgA were seen in 12 out of the 20 cases. Colloid 
bodies  have  been  noted  in  other  dermatoses  but  their  occurrence  in  large 
numbers in the lower epidermis and upper der
mis is characteristic of LP. In our study, CB's were noted in  60% of cases. 
Linear  IgG,C3 at  the BMZ with shaggy fibrinogen was  seen  in  the case  of 
LE/LP overlap . IgG, C3deposition at the BMZ  which resembled those of LE 
was present in  three cases of classical LP. Kulthanan et al in their study noted 
shaggy fibrin deposition at the DEJ  in 56% of cases & CB’s in 22% of cases. 
Some of their patients also showed DIF features resembling  LE  131.  In their 
study, Lim et al reported shaggy fibrin 
along  BMZ   in  93%  of  the  cases,  &colloid  bodies   in  87%  of  the  cases. 
However they did not find any immunoglobulin deposition along the basement 
membrane132.
    The simultaneous deposition of complement fragments,  immunoglobulins 
and fibrin in lesions of LP point to the activation of complement and a fi
brinogen cascade. These products in turn act as chemoattractants for leucocytes 
leading to the in
flammatory response in LP, which perpetuates the basal cell damage. Whether 
these events are a cause or effect  of pathological  processes in lichen planus 
needs to be elucidated.
Interesting observations: 
Zosteriform LP:
A 60 year old male had  zosteriform LP on trunk coexisting with linear LP in 
limb.
        Dermatomal lichen planus can erupt following healed herpes zoster of the 
same location, an example of the Wolf isotopic response or in extremely rare 
cases, linear or segmental distributions appear de novo on previously normal, 
non-traumatized skin, as in our patient114-118. Although case reports of de novo 
dermatomal LP have been reported some authors believe that true zosteriform 
LP does not exist except in cases arising on the site of healed herpes zoster  
However,  Lutz  presented  two  cases  of  zosteriform  lichen  planus  without 
evidence of preceding viral disease113.
        In our patient, the distribution of lesions followed the T9 dermatome. The 
patient denied prior history of herpes zoster. The eruption on the trunk seemed 
to follow a true dermatome rather than in the pattern the lines of Blaschko. In 
many of these cases, it is difficult to differentiate the two. So it remains 
unknown if there are two separate forms of unilateral, de novo lichen planus, 
one type arising in the lines of Blaschko  (Blaschkonian lichen planus)  and the 
other arising within one or more dermatomes. In our case, zosteriform pattern 
on the trunk was present in addition to linear pattern on the limb which is so far 
not reported in the literature.
LP in albino child:
Lichen planus  presented as pruritic  scaly reddish brown papules on trunk & 
limbs in a 4 year old child with albinism. Histology showed all the findings of a 
classical lichen planus except for pigment incontinence.
LE/LP overlap:
A 55 year old female presented with bluish red scaly papules  and  plaques on 
the lower lip, upper chest, legs  and forearms. 
t
Evaluation of laboratory data including antinuclear antibody were within 
normal limits.
Histopathologic examination revealed hyperkeratosis, hypergranulosis, 
follicular plugging, dermal mucin and  perivascular & perifollicular infiltrate of 
lymphocytes with patchy lymphocytic infiltrate at BMZ. Vacuolar alteration of 
basal layer and colloid bodies were seen . DIF showed linear IgG,C3 at the 
BMZ with shaggy fibrinogen.
Our patient had  the characteristic clinical and histological fearures of both LE 
and LP. Coexistence of these two diseases has been described by Romero et 
al133. Jamison et al suggest such cases should be followed up to confirm whether 
these are  coexistent diseases or unusual variant of LE134.
Malignant change in hypertrophic LP:
Squamous cell carcinoma developing from lesion of  hypertrophic LP was noted 
in one case. A 51year old female presented with lesions over legs for 8 years. 
Over the last  six months, a  small,  hard growth had appeared in left  leg that 
enlarged to the present size. There was no history of trauma or any application 
of  irritants  at the  site. A large verrucous growth with some ulceration and 
crusting over the surface was present. Regional lymph nodes were not palpable 
and systemic examination was normal. Biopsy specimens were obtained from 
the edge and from the overlying tumor. The first one showed findings typical of 
 
hypertrophic LP. The second specimen showed features of a well-differentiated 
squamous cell carcinoma comprising of epidermal proliferation with horn pearls 
and  scattered  atypical  mitotic  figures.  Neoplastic  transformation  of  lichen 
planus  is  a  rare  event.  However,  squamous  cell  carcinoma  may  develop  in 
0.3%-3% of patients with the oral form of the disease135. On the other hand, only 
about 30 cases arising in cutaneous lichen planus have been reported136. 
                                  
Summary
Incidence:
Lichen planus constituted 0.16 percent of the total patients diagnosed during the 
period of study.
Age:
     51% of  patients  were between  31-50 years of age. Childhood LP accounted 
for about 9% of cases.
 Sex:
     No sexual predilection was seen.
Familial involvement& seasonal variation:
     There was no family history and seasonal variation was not seen.
Morphology and distribution of lesions:
      Papules were present in 79%  and  plaques were present in 14% of the 
cases . Initial site of onset was limbs in 63% , trunk in21% ,face in 8%, oral 
mucosa in 6% and genital mucosa in 2% .Oral mucosa was involved in 21% 
.Nail involvement was noted in17%.Palmoplantar involvement was present in 
20%.Koebner’s phenomenon was seen in  33%.
2
Clinical patterns:
Classical LP was the commonest seen in 60 cases followed by hypertrophic LP 
seen in 10 cases. A linear pattern was seen in 5 cases. A zosteriform pattern in 
trunk  was  present  in  one  case  of  linear  LP  of  the  limb.  3  cases  had  LP 
pigmentosus ,4 patients had eruptive LP,1 had actinic LP and 2 patients had 
follicular  LP.  1  patient  had  features  of  LE/LP overlap.Isolated  oral  LP  and 
annular LP were present in 2 cases each.
Histopathology:  
Histopathological  features  were  consistent  with  classical  LP  in  30  cases  , 
hypertrophic LP in 9 cases, Follicular LP in 2 , LP pigmentosus in 3, actinic LP 
in  1,oral   LP  in  2,  LE/LP  overlap  in  1,drug  induced  LP in  2.  Features  of 
squamous  cell  carcinoma  was  present  in  the  warty  growth  from a  case  of 
hypertrophic LP .
Immunofluorescence:
DIF study done in 20 patients showed ragged fibrinogen  deposits in basement 
membrane zone in all the patients.  Colloid bodies were seen in 60%. Linear 
IgG, C3 at the BMZ with shaggy fibrinogen was seen in the LE/LP overlap 
syndrome. Linear IgG,C3 at the BMZ with shaggy fibrinogen was also present 
in  three cases of classical LP.
Associations:
In this study,  the diseases which were found to be associated were diabetes 
mellitus, hypertension, hypothyroidism, vitiligo & alopecia areata .Interesting 
presentation of lichen planus in a case of albinism was seen.
Malignant change: 
 A case of hypertrophic LP developed squamous cell carcinoma.
                           Conclusion
 1.The incidence of Lichen planus in this study was 0.16% .
2. Most of the patients were in 4th and 5th decade.  
3. Classical type was the commonest followed by hypertrophic type & linear 
variant next in frequency. 
4.  Limbs were the most frequent initial site of onset. 
5.  Concomitant  mucosal,  genital,  nail  and  palmoplantar  involvement  was 
common. 
6. There was a complete correlation be
tween clinical types and histo
pathological features in all the 50 patients biopsied.
7. The characteristic  findings of ragged fibrin at BMZ and colloid bodies with 
IgM and C 3 & to a lesser extent with other classes of immunoglobulins were 
observed in the immunofluorescence study.
8.  A case of zosteriform  lichen planus coexisting with linear LP was present.
9. Association of other immune mediated diseases was noted.
10. Malignant change was observed in a case of hypertrophic lichen planus.
11.Interesting  presentation of  lichen planus in a case of albinism was noted.
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PROFORMA
Name:                                                                                                        Occupation:
Age:                                                                                                             Income:
Sex:                                                                                Socioeconomic Status: 
Address: 
H/o Skin lesion:
 Duration
 Site of first lesion
 Evolution  of the lesion 
H/o Mucosal involvement:
 Oral
 Genital
H/o pruritus / burning / pain over the lesions
Healing spontaneously or with treatment
Heals with hyperpigmentation or hypopigmentation
H/o drug intake / infection
H/o lesions following trauma
H
General H/o:
 HT / TB / DM / Heart disease
 Malignancy
 Smoking / alcohol
 Marital status
 Family H/o similar illness
 H/o other autoimmune diseases in the patient
Condition on first visit:
 General condition
 Weight
 BP
 CVS
 RS
 Abdomen
 Others
     Active skin lesion:
 Number, site
 Distribution – Groups / discrete along lines of trauma
• Healing lesions
• Mucosal lesions
•
• Palms / soles involvement
• Hair involvement
• Nail involvement
• Any other skin lesions
Investigations:
 Blood sugar
 LFT
 RFT
 Hemogram
 Blood VDRL
 Anti HCV antibody
 Biopsy
• Site
• Findings
DIF  findings:
